Medicaid Pharmacy

 

Drug Utilization Review (DUR) and Pharmaceutical and Therapeutics (P&T) Websites Update
The Drug Utilization Review (DUR) and Pharmaceutical and Therapeutics (P&T) websites are temporarily inaccessible due to the Change Healthcare outage. Meeting notices will be posted on this page until the DUR and P&T websites are operational again.

 

The purpose of the Iowa Medicaid Pharmacy page is to guide providers to available Iowa Medicaid Pharmacy resources.

 

Pharmaceutical and Therapeutics (P&T) Committee

House File 653 established a requirement for the Pharmaceutical and Therapeutics (P&T) Committee and the Drug Utilization Review (DUR) Commission to request and consider information from individuals who possess scientific or medical training with respect to drugs and biological products for rare diseases and drugs and biological products that are genetically targeted when making recommendations or determinations regarding beneficiary access.

To learn more about the process for written public comment submission for drugs and rare diseases for the upcoming P&T Committee meeting on August 15, 2024, click here.

Pharmaceutical and Therapeutics Committee

Drug Utilization Review (DUR) Committee

House File 653 established a requirement for the Pharmaceutical and Therapeutics (P&T) Committee and the Drug Utilization Review (DUR) Commission to request and consider information from individuals who possess scientific or medical training with respect to drugs and biological products for rare diseases and drugs and biological products that are genetically targeted when making recommendations or determinations regarding beneficiary access.

To learn more about the process for written public comment submission for drugs and rare diseases for the upcoming August 7, 2024, DUR meeting, click here.

Medicaid Pharmacy Program Documents

 

To see archived pharmacy documents, please click here.

 

Pharmacy Rate Setting

For telephone accessibility assistance, use the resources below.